Predicting clinical response to anticancer drugs using 3D-bioprinted tumor models for personalized therapy

Project description

Recreating a patient's tumour ecoystem with 3D printing will foster precision treatment

Fields of science

• medical and health sciences › clinical medicine › cancer

Programme(s)

• H2020-EU.1.1. - EXCELLENT SCIENCE - European Research Council (ERC)

Topic(s)

• ERC-2019-POC - ERC Proof of Concept Grant

Call for proposal

ERC-2019-PoC
See other projects for this call

Funding Scheme

ERC-POC-LS - ERC Proof of Concept Lump Sum Pilot

Host institution

TEL AVIV UNIVERSITY

Address

Ramat Aviv
69978 Tel Aviv
Israel

Activity type

Higher or Secondary Education Establishments

EU contribution

€ 150 000

Beneficiaries (1)

TEL AVIV UNIVERSITY

Israel

EU contribution

€ 150 000

Address

Ramat Aviv
69978 Tel Aviv

Activity type

Higher or Secondary Education Establishments